Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover

investors.com/news/technology/verve-therapeutics-stock-eli-lilly-buyout-gene-editing-stocks

Verve Therapeutics stock nearly doubled Tuesday after Eli Lilly agreed to buy the gene-editing company for up to $1.3 billion.
The post Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-06-17 13:14:27.
The Entire Business World on a Single Page. Free to Use →